JP2023519965A5 - - Google Patents
Info
- Publication number
- JP2023519965A5 JP2023519965A5 JP2022559518A JP2022559518A JP2023519965A5 JP 2023519965 A5 JP2023519965 A5 JP 2023519965A5 JP 2022559518 A JP2022559518 A JP 2022559518A JP 2022559518 A JP2022559518 A JP 2022559518A JP 2023519965 A5 JP2023519965 A5 JP 2023519965A5
- Authority
- JP
- Japan
- Prior art keywords
- feature
- approximately
- use described
- dextromethorphan
- bupropion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024212992A JP7890382B2 (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Applications Claiming Priority (11)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063002132P | 2020-03-30 | 2020-03-30 | |
| US63/002,132 | 2020-03-30 | ||
| US202063016178P | 2020-04-27 | 2020-04-27 | |
| US63/016,178 | 2020-04-27 | ||
| US202063032517P | 2020-05-29 | 2020-05-29 | |
| US63/032,517 | 2020-05-29 | ||
| US202063032567P | 2020-05-30 | 2020-05-30 | |
| US63/032,567 | 2020-05-30 | ||
| US16/894,713 US10898453B2 (en) | 2013-11-05 | 2020-06-05 | Bupropion as a modulator of drug activity |
| US16/894,713 | 2020-06-05 | ||
| PCT/US2021/024718 WO2021202419A1 (en) | 2020-03-30 | 2021-03-29 | Use of bupropion and dextromethorphan combinations for treating neurological disorders |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212992A Division JP7890382B2 (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023519965A JP2023519965A (ja) | 2023-05-15 |
| JP2023519965A5 true JP2023519965A5 (cg-RX-API-DMAC7.html) | 2023-07-20 |
| JP7637150B2 JP7637150B2 (ja) | 2025-02-27 |
Family
ID=77930161
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022559518A Active JP7637150B2 (ja) | 2020-03-30 | 2021-03-29 | 神経疾患を治療するためのブプロピオンおよびデキストロメトルファンの組み合わせの使用 |
| JP2024212992A Active JP7890382B2 (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024212992A Active JP7890382B2 (ja) | 2020-03-30 | 2024-12-06 | アルツハイマー病に関連する焦燥を治療するための医薬 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4125837A4 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7637150B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220161414A (cg-RX-API-DMAC7.html) |
| CN (1) | CN115697314A (cg-RX-API-DMAC7.html) |
| CA (1) | CA3179048A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021202419A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12194006B2 (en) | 2013-11-05 | 2025-01-14 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11433067B2 (en) | 2013-11-05 | 2022-09-06 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12109178B2 (en) | 2013-11-05 | 2024-10-08 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11969421B2 (en) | 2013-11-05 | 2024-04-30 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11534414B2 (en) | 2013-11-05 | 2022-12-27 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12569479B2 (en) | 2016-05-25 | 2026-03-10 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US12472156B2 (en) | 2020-06-05 | 2025-11-18 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US20250073188A1 (en) | 2020-06-05 | 2025-03-06 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| US12433884B2 (en) | 2020-06-05 | 2025-10-07 | Antecip Bioventures Ii Llc | Compounds and combinations thereof for treating neurological and psychiatric conditions |
| CN122440635A (zh) | 2020-12-01 | 2026-07-24 | 安泰赛普生物风投二代有限责任公司 | 用于降低抑郁症患者的自杀风险的安非他酮和右美沙芬 |
| CA3227072A1 (en) * | 2021-07-21 | 2023-01-26 | Antecip Bioventures Ii Llc | Treatment of depression |
| JP2025517368A (ja) * | 2022-05-17 | 2025-06-05 | アンテシップ バイオベンチャーズ トゥー エルエルシー | うつ病の治療 |
| US11717518B1 (en) | 2022-06-30 | 2023-08-08 | Antecip Bioventures Ii Llc | Bupropion dosage forms with reduced food and alcohol dosing effects |
| US12036191B1 (en) | 2022-06-30 | 2024-07-16 | Antecip Bioventures Ii Llc | Treatment of poor metabolizers of dextromethorphan with a combination of bupropion and dextromethorphan |
| US12156914B2 (en) | 2022-06-30 | 2024-12-03 | Axsome Therapeutics, Inc. | Pharmaceutical compositions comprising bupropion and cysteine |
| US11730706B1 (en) | 2022-07-07 | 2023-08-22 | Antecip Bioventures Ii Llc | Treatment of depression in certain patient populations |
| US12194036B2 (en) | 2022-07-07 | 2025-01-14 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| US11844797B1 (en) | 2023-04-20 | 2023-12-19 | Antecip Bioventures Ii Llc | Combination of dextromethorphan and bupropion for treating depression |
| KR20250114110A (ko) * | 2022-11-28 | 2025-07-28 | 안테씨프 바이오벤쳐스 투 엘엘씨 | 약물 활성의 조절제로서의 부프로피온 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3981403A1 (en) * | 2013-11-05 | 2022-04-13 | Antecip Bioventures II LLC | Compositions and methods comprising bupropion or related compounds and dextromethorphan |
| US11234946B2 (en) * | 2013-11-05 | 2022-02-01 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US9763932B2 (en) * | 2013-11-05 | 2017-09-19 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
| US10898453B2 (en) * | 2013-11-05 | 2021-01-26 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US11007189B2 (en) * | 2013-11-05 | 2021-05-18 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
| US10080727B2 (en) * | 2013-11-05 | 2018-09-25 | Antecip Bioventures Ii Llc | Compositions and methods for increasing the metabolic lifetime of dextromethorphan and related pharmacodynamic effects |
| US11273134B2 (en) * | 2013-11-05 | 2022-03-15 | Antecip Bioventures Ii Llc | Bupropion as a modulator of drug activity |
-
2021
- 2021-03-29 CN CN202180038675.3A patent/CN115697314A/zh active Pending
- 2021-03-29 EP EP21779322.3A patent/EP4125837A4/en active Pending
- 2021-03-29 KR KR1020227037493A patent/KR20220161414A/ko active Pending
- 2021-03-29 JP JP2022559518A patent/JP7637150B2/ja active Active
- 2021-03-29 CA CA3179048A patent/CA3179048A1/en active Pending
- 2021-03-29 WO PCT/US2021/024718 patent/WO2021202419A1/en not_active Ceased
-
2024
- 2024-12-06 JP JP2024212992A patent/JP7890382B2/ja active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023041862A5 (cg-RX-API-DMAC7.html) | ||
| JP2023541430A5 (cg-RX-API-DMAC7.html) | ||
| FI3908270T3 (fi) | Faanin ja bupropionin yhdistelmä masennuksen hoitoon aasialaisilla potilailla | |
| JP2023541432A5 (cg-RX-API-DMAC7.html) | ||
| KR20230145525A (ko) | 과다 졸림증을 치료하기 위한 방법 및 조성물 | |
| HUE029677T2 (hu) | Készítmények centrálisan mediált émelygés és hányás kezelésére | |
| JPH05213741A (ja) | デプレニル/l−ドーパ/カルビドーパ含有の医薬組成物 | |
| JP2008500288A (ja) | 経口治療用化合物の供給系 | |
| Fischer et al. | Efficacy and tolerability of ambroxol hydrochloride lozenges in sore throat | |
| RU2004135563A (ru) | Лекарственное средство для лечения повышенной активности мочевого пузыря | |
| JP5828609B2 (ja) | 持続性解熱鎮痛消炎剤 | |
| Gupta et al. | Intermittent short duration therapy with fluconazole is effective for tinea capitis | |
| JP2022553888A5 (cg-RX-API-DMAC7.html) | ||
| JP2024531799A5 (cg-RX-API-DMAC7.html) | ||
| JP2023516753A5 (cg-RX-API-DMAC7.html) | ||
| CA2893836C (en) | A combination medicament comprising phenylephrine and paracetamol | |
| US20190224208A1 (en) | Pharmaceutical composition for treating premature ejaculation and method for treating premature ejaculation | |
| EP0529898A1 (en) | Potentiation of the antitussive effect of dextromethorphan with acetaminophen (paracetamol) | |
| US20170087104A1 (en) | Medicament | |
| Miach et al. | Double‐blind cross‐over evaluation of mazindol in the treatment of obese hypertensive patients | |
| JP2005527634A (ja) | 緊張型頭痛の治療にミルナシプランを使用する方法 | |
| JP2023507764A5 (cg-RX-API-DMAC7.html) | ||
| RU2611383C2 (ru) | Комбинированный препарат для устранения симптомов и лечения острых респираторных вирусных инфекций и гриппа | |
| JP2024541770A5 (cg-RX-API-DMAC7.html) | ||
| Beceiro et al. | Individualization of drug therapy for the parkinsonian patient |